Drug Type CAR-T |
Synonyms- |
Target |
Mechanism TF antigen modulators(Thomsen–Friedenreich antigen modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Preclinical | DE | 17 Oct 2023 | |
Leukemia | Preclinical | DE | 17 Oct 2023 | |
Solid tumor | Preclinical | DE | 17 Oct 2023 | |
Solid tumor | Preclinical | DE | 17 Oct 2023 |